Photodynamic Therapy Market Forecast To Reach $2.04 Billion By 2030: Key Growth Drivers And Industry Trends
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Photodynamic Therapy Market CAGR Outlook And Future Development#_x000D_
The photodynamic therapy market size has experienced significant expansion over recent years. It is anticipated to increase from $1.53 billion in 2025 to $1.62 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. Historically, this market’s expansion can be linked to the rising occurrence of skin cancer and precancerous lesions, the increasing preference for minimally invasive therapies, initial positive clinical evaluation of photosensitizers, heightened awareness regarding non-surgical treatment options, and the availability of medical devices utilizing laser technology._x000D_
_x000D_
The photodynamic therapy market is projected to experience robust growth in the near future. It is anticipated to reach $2.04 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.9%. This expansion during the forecast period stems from advancements in novel photosensitizer formulations, the broadening of its applications beyond oncology, a rising demand for outpatient therapies, increasing investment in cancer treatment infrastructure, and a growing preference for targeted and precision therapies. Significant trends for the forecast period include the increasing use of photodynamic therapy in oncology, its growing adoption in dermatology and aesthetic treatments, the development of next-generation photosensitizers, a shift towards minimally invasive cancer treatments, and the rising application of combination therapy approaches._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Photodynamic Therapy Market Demand Drivers: What’s Powering Industry Growth?#_x000D_
The increasing occurrence of skin cancer is driving expansion in the photodynamic therapy market. Skin cancer stands out as the most frequently diagnosed form of cancer. Despite making up only about 1% of all skin cancers, melanoma is responsible for a significant proportion of fatalities linked to skin cancer. Photodynamic treatment (PDT) involves the application of a light-sensitive drug alongside powerful light to eliminate cancerous cells. A physician applies a lotion containing light-sensitizing chemicals directly to the affected skin cancer site and its adjacent regions. As an illustration, data from Cancer Australia, an Australia-based government agency, revealed that in 2023, around 8,257 fresh diagnoses of melanoma of the skin were made, which represented 2.6% of all cancer-related mortalities. Consequently, the growing incidence of skin cancer is anticipated to stimulate the expansion of the photodynamic therapy market in the foreseeable future._x000D_
_x000D_
#Photodynamic Therapy Market Segment Landscape: Which Areas Lead Development?#_x000D_
The photodynamic therapy market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Drugs, Devices_x000D_
2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications_x000D_
3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations_x000D_
2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems) _x000D_
_x000D_
#Photodynamic Therapy Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_
Leading companies within the photodynamic therapy (PDT) market are increasingly concentrating on conducting clinical trials to assess PDT’s effectiveness when combined with various medications, aiming for superior therapeutic outcomes. Photodynamic therapy itself involves the utilization of light-activated compounds to selectively target and eliminate cancerous or diseased cells. For instance, Kintara Therapeutics, a US-based biotechnology company, initiated a clinical trial in February 2024 for its REM-001 therapy, which targets cutaneous metastatic breast cancer (CMBC). This open-label study (NCT05374915) involves 15 patients and evaluates the second-generation PDT agent REM-001 at a 0.8 mg dose. The trial’s objective is to optimize the study design in advance of a Phase 3 trial, with a focus on the Best Overall Objective Response Rate (bORR) within 24 weeks, and primary endpoints measuring complete and partial responses within the treated fields._x000D_
_x000D_
#Photodynamic Therapy Market Industry Leaders And Competitive Landscape#_x000D_
Major companies operating in the photodynamic therapy market are Galderma S.A., Bausch Health, Lumenis Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Hologic Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de Produtos Farmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc. _x000D_
_x000D_
#View The Full Photodynamic Therapy Market Report:#_x000D_
_x000D_
#Photodynamic Therapy Market Largest Region By Revenue And Market Share#_x000D_
North America was the largest region in the photodynamic therapy market in 2025. The regions covered in the photodynamic therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
